Lindsey Herrel, MD, MS
Urology
2800 Plymouth Rd, Bldg 16, Rm 109E
Ann Arbor, MI 48109-2800
Manage Your Profile
About
Lindsey Herrel MD, MS is a practicing urologic oncologist at the University of Michigan. She is a graduate of the Saint Louis University School of Medicine and completed her residency in urology at Emory University. She received a Master’s of Science in Health and Health Care Research at the University of Michigan where she completed a fellowship in Urologic Oncology and Health Services Research. Her clinical interests focus on the care of patients with urologic malignancies, including cancers of the kidney, testis, prostate, bladder, adrenal gland and penis. Her primary areas of research interest focus in health policy and include understanding the impact of payment reform for safety net hospitals and vulnerable populations.
Qualifications
-
FellowshipUniversity of Michigan–Ann Arbor, Ann Arbor, United States
2014 - 2017
Clinical Fellowship
-
ResidencyEmory University, Atlanta, United States
2009 - 2014
Residency
Center Memberships
-
Center MemberCenter for Global Health Equity
-
Center MemberRogel Cancer Center
-
Center MemberInstitute for Healthcare Policy and Innovation
Research Overview
Dr. Herrel’s research focuses on population-based analyses to assess and anticipate the impact of healthcare reform on safety net hospitals and vulnerable or underserved populations. She also has research interests in understanding how organizational structure within a health system (e.g. Accountable Care Organizations) impacts delivery of care.
Recent Publications
-
Sekar RR, Zebib L, Stensland KD, Herrel LA. Journal of the National Cancer Institute, 2025 Sep 1; 117 (9): 1934 - 1937.Journal ArticleStructural inequities in the availability of prostate cancer clinical trial opportunities
DOI:10.1093/jnci/djaf047 PMID: 40036373 -
Hill DC, Kaufman SR, Dall C, Guro P, Leick S, Chachlani P, Liu X, Shay A, Oerline M, Sekar RR, Herrel LA, Hollenbeck BK, Shahinian VB, Srivastava A. JAMA Network Open, 2025 Jul 1; 8 (7):Journal ArticleRacial Differences in Care Quality Among Men With Newly Diagnosed Prostate Cancer
DOI:10.1001/jamanetworkopen.2025.23038 PMID: 40705334 -
Krischak MK, Nam CS, Luckenbaugh AN, Herrel LA. Cancer, 2025 Oct 3; 131 (13):Journal ArticleReply to “Promoting retention through belonging: A path to gender equity in oncologic specialties”
DOI:10.1002/cncr.35948 -
Srivastava A, Kaufman S, Liu X, Maganty A, Shay A, Oerline M, Dall C, Faraj K, Leick S, Guro P, Hill D, Nguyen T, Herrel L, Hollenbeck B, Shahinian V. Journal of Urology, 2025 Apr 10; 213 (5S): e216Journal ArticleIP04-16 INCREASED PRACTICE-LEVEL MEDICARE ADVANTAGE PENETRATION MAY INCREASE TREATMENT IN TRADITIONAL MEDICARE BENEFICIARIES WITH PROSTATE CANCER
DOI:10.1097/01.ju.0001109780.20015.87.16 -
Zebib L, Herrel L, Dunn R, Sekar R. Journal of Urology, 2025 Apr 10; 213 (5S): e1292Journal ArticleIP25-22 UNDERSTANDING THE IMPACT OF HISTORICAL REDLINING ON PROSTATE CANCER CARE QUALITY AND TREATMENT PATTERNS AND THE ASSOCIATION WITH MODERN METRICS OF DISPARITY
DOI:10.1097/01.ju.0001110172.53107.6f.22 -
Srivastava A, Kaufman SR, Liu X, Maganty A, Shay A, Oerline M, Dall C, Faraj KS, Guro P, Hill D, Nguyen T, Herrel LA, Hollenbeck BK, Shahinian VB. Cancer Medicine, 2025 Mar 1; 14 (6):Journal ArticleSpillover Effects of Medicare Advantage on Traditional Medicare Beneficiaries With Prostate Cancer
DOI:10.1002/cam4.70796 PMID: 40111071 -
Dhir A, Maganty A, Stensland KD, Herrel LA, Sekar RR. Urologic Oncology Seminars and Original Investigations, 2025 Mar 1; 43 (3): 10Journal ArticleTHE ASSOCIATION BETWEEN RACE/ETHNICITY AND TRUST IN SOURCES OF CANCER INFORMATION IN PATIENTS WITH UROLOGIC CANCERS
DOI:10.1016/j.urolonc.2024.12.027 -
Sekar RR, Maganty A, Stensland KD, Herrel LA. JCO Oncology Practice, 2025 Feb 1; 21 (2): 235 - 244.Journal ArticleAssociation of Community-Level Social Vulnerability with Clinical Trial Discussion and Participation among Cancer Survivors
DOI:10.1200/OP.24.00206 PMID: 39208361
Featured News & Stories